FDCDDQ
UTHR icon

Federation des caisses Desjardins du Quebec’s United Therapeutics UTHR Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.33M Buy
11,689
+434
+4% +$244K 0.02% 452
2026
Q1 		$6.68M Sell
11,255
-1,496
-12% -$745K 0.02% 396
2025
Q4 		$6.21M Buy
12,751
+6,853
+116% +$3.19M 0.02% 393
2025
Q3 		$2.47M Buy
5,898
+1,813
+44% +$610K 0.01% 653
2025
Q2 		$1.17M Sell
4,085
-4,548
-53% -$1.36M 0.01% 813
2025
Q1 		$2.66M Buy
8,633
+936
+12% +$321K 0.01% 527
2024
Q4 		$2.72M Sell
7,697
-3,089
-29% -$1.14M 0.01% 497
2024
Q3 		$3.86M Buy
10,786
+9,198
+579% +$3.11M 0.02% 396
2024
Q2 		$506K Buy
1,588
+131
+9% +$34.7K ﹤0.01% 937
2024
Q1 		$331K Buy
1,457
+720
+98% +$162K ﹤0.01% 964
2023
Q4 		$162K Buy
737
+110
+18% +$25.4K ﹤0.01% 1004
2023
Q3 		$142K Buy
627
+12
+2% +$2.76K ﹤0.01% 1038
2023
Q2 		$136K Buy
615
+34
+6% +$7.53K ﹤0.01% 1078
2023
Q1 		$130K Buy
581
+351
+153% +$86.5K ﹤0.01% 1082
2022
Q4 		$64K Hold
230
– – ﹤0.01% 1381
2022
Q3 		$48.2K Hold
230
– – ﹤0.01% 1516
2022
Q2 		$54.2K Hold
230
– – ﹤0.01% 1507
2022
Q1 		$41.3K Hold
230
– – ﹤0.01% 1640
2021
Q4 		$49.7K Hold
230
– – ﹤0.01% 1597
2021
Q3 		$42.5K Hold
230
– – ﹤0.01% 1650
2021
Q2 		$41.3K Hold
230
– – ﹤0.01% 1665
2021
Q1 		$38.5K Sell
230
-460
-67% -$76.7K ﹤0.01% 1623
2020
Q4 		$105K Buy
690
+460
+200% +$60.4K ﹤0.01% 1265
2020
Q3 		$23.2K Hold
230
– – ﹤0.01% 1449
2020
Q2 		$27.8K Hold
230
– – ﹤0.01% 1358
2020
Q1 		$21.8K Sell
230
-2,527
-92% -$240K ﹤0.01% 1473
2019
Q4 		$243K Sell
2,757
-5,564
-67% -$490K ﹤0.01% 997
2019
Q3 		$664K Sell
8,321
-5,133
-38% -$413K 0.01% 717
2019
Q2 		$1.05M Sell
13,454
-10,580
-44% -$989K 0.02% 632
2019
Q1 		$2.82M Sell
24,034
-587
-2% -$68.4K 0.04% 319
2018
Q4 		$2.68M Buy
24,621
+5,967
+32% +$692K 0.05% 319
2018
Q3 		$2.39M Buy
18,654
+1,386
+8% +$171K 0.03% 398
2018
Q2 		$1.96M Buy
17,268
+1,865
+12% +$205K 0.03% 475
2018
Q1 		$1.73M Buy
15,403
+6,597
+75% +$838K 0.03% 495
2017
Q4 		$1.3M Buy
8,806
+225
+3% +$28.6K 0.02% 570
2017
Q3 		$1.01M Sell
8,581
-16,428
-66% -$2.1M 0.02% 608
2017
Q2 		$3.24M Sell
25,009
-942
-4% -$118K 0.05% 279
2017
Q1 		$3.51M Buy
+25,951
New +$3.93M 0.07% 244

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Federation des caisses Desjardins du Quebec's UTHR Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its United Therapeutics (UTHR) stake by 3.9% in Q2 2026, buying an estimated $244K and bringing the position to 11,689 shares worth $6.33M. The position accounts for 0.02% of the portfolio, ranked #452.

Federation des caisses Desjardins du Quebec first reported a position in UTHR in Q1 2017 and has held it in 38 quarters since. The position peaked at $6.68M in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 11,689 shares of United Therapeutics worth $6.33M as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 434 United Therapeutics shares in Q2 2026, an estimated $244K.
  • United Therapeutics made up 0.02% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #452 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in United Therapeutics in Q1 2017 and has held it in 38 quarters since.
  • Federation des caisses Desjardins du Quebec's United Therapeutics position peaked at $6.68M in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.